文献速递炎症性肠病

炎症性肠病提供者专业化:医疗质量与结局

Provider Specialization in Inflammatory Bowel Diseases: Quality of Care and Outcomes.
PubMed 文献 · Clin Gastroenterol Hepatol · 2024-06-04

该回顾性队列研究利用Optum去标识化数据库(2000-2020年),纳入772例儿童和2864例成人新诊断炎症性肠病患者,评估治疗胃肠病学家的炎症性肠病专注度(门诊就诊中炎症性肠病比例>第90百分位)与过程指标及临床结局的关联。儿童中无显著关联;成人中,专注度高的提供者与更多生物制剂、联合治疗、影像和内镜使用以及克罗恩病更少美沙拉秦使用相关(P<.05),但住院和手术率无关联。

要点

  • 儿童炎症性肠病患者中,提供者专注度与所有过程和结局指标均无显著关联。
  • 成人中,炎症性肠病专注度高的提供者与更多生物制剂、联合治疗、影像和内镜使用相关(P<.05)。
  • 成人克罗恩病中,专注度高的提供者与更少美沙拉秦使用相关,但住院和手术率无关联。

核心结论

  • 成人炎症性肠病诊疗随提供者专业化程度而变化,鉴于其日益复杂的特性,可能需要新方法来标准化诊疗。

研究设计与样本

  • 回顾性队列研究,使用Optum去标识化Clinformatics Data Mart数据库(2000-2020年)中新诊断的炎症性肠病患者数据。
  • 暴露变量为治疗胃肠病学家是否具有炎症性肠病专注度(炎症性肠病就诊次数占总门诊就诊次数>第90百分位)。
  • 研究纳入772名儿童(由493名提供者治疗)和2864名成人(由2076名提供者治疗)。

主要发现

  • 儿童中,提供者专注度与过程或结局指标之间的关联均无统计学显著性。
  • 成人中,炎症性肠病专注度高的提供者诊疗与更多生物制剂使用、联合治疗、影像和内镜检查以及克罗恩病更少美沙拉秦使用相关(所有比较P<.05),但与其他过程指标无关联。
  • 在较晚时期(2013-2020年 vs 2004-2012年),生物制剂处方更频繁而麻醉剂更少(两者P<.05)。
  • 住院率和手术率与炎症性肠病专注度或时期均无关联。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Management of inflammatory bowel diseases (IBD) is complex and variation in care has been well-documented. However, the drivers of practice variation remain unexplored. We examined variation based on the treating gastroenterologist's IBD focus (proportion of outpatient visits for IBD). METHODS: We conducted a retrospective cohort of newly diagnosed patients with IBD using data from Optum's deidentified Clinformatics Data Mart Database (2000-2020). The exposure variable was whether the treating gastroenterologist had an IBD focus (>90th percentile of IBD visits/total outpatient visits). We used adjusted regression models to evaluate associations between provider IBD focus and process measures (use of mesalamine, corticosteroid, biologic, and narcotic medications and endoscopic or radiographic imaging) and clinical outcomes (time to IBD-related hospitalization and bowel resection surgery). We tested for change in treatment patterns over time by including an interaction term for study era (2004-2012 vs 2013-2020). RESULTS: The study included 772 children treated by 493 providers and 2864 adults treated by 2076 providers. In children, none of the associations between provider focus and process or outcome measures were significant. In adults, care from an IBD-focused provider was associated with more use of biologics, combination therapy, and imaging and endoscopy, and less mesalamine use for Crohn's disease (P < .05 for all comparisons) but not with other process measures. Biologics were prescribed more frequently and narcotics less frequently during the later era (P < .05 for both). Hospitalization and surgery rates were not associated with IBD focus or era. CONCLUSIONS: IBD care for adults varies by provider specialization. Given the evolving complexity, novel methods may be needed to standardize care.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Lewis JD, Brensinger CM, Parlett LE, et al. Provider Specialization in Inflammatory Bowel Diseases: Quality of Care and Outcomes. Clin Gastroenterol Hepatol. 2024. PMID: 38844254. doi:10.1016/j.cgh.2024.05.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。